Takeda Pharmaceutical Company Limited
TKPHF
$28.63
-$1.45-4.81%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.18% | 2.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.18% | 2.09% | |||
| Cost of Revenue | 3.04% | 6.86% | |||
| Gross Profit | -9.33% | -0.15% | |||
| SG&A Expenses | -1.70% | 4.19% | |||
| Depreciation & Amortization | -7.03% | 7.80% | |||
| Other Operating Expenses | 421.67% | -187.04% | |||
| Total Operating Expenses | 18.69% | -3.51% | |||
| Operating Income | -97.56% | 31.70% | |||
| Income Before Tax | -78.44% | -8.36% | |||
| Income Tax Expenses | -90.81% | -30.77% | |||
| Earnings from Continuing Operations | -74.78% | 1.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 26.51% | -25.43% | |||
| Net Income | -74.81% | 1.34% | |||
| EBIT | -97.56% | 31.70% | |||
| EBITDA | -56.66% | 18.35% | |||
| EPS Basic | -74.85% | 0.44% | |||
| Normalized Basic EPS | -116.73% | 24.63% | |||
| EPS Diluted | -74.43% | 0.05% | |||
| Normalized Diluted EPS | -117.01% | 24.14% | |||
| Average Basic Shares Outstanding | 0.14% | 0.89% | |||
| Average Diluted Shares Outstanding | -1.52% | 1.29% | |||
| Dividend Per Share | -100.00% | -- | |||
| Payout Ratio | 60.18% | -0.93% | |||
